Metastases

Type: Keyphrase
Name: Metastases
First reported 13 hours ago - Updated 13 hours ago - 1 reports

Y-90 radioembolization: A new treatment for hepatic metastases from breast cancer

Share this article:Yttrium-90 (Y-90) radioembolization is a minimally invasive treatment that may slow disease progression in breast cancer that has metastasized to the liver. It delivers cancer-killing radiation directly to the tumor, sparing healthy ... [Published Chemotherapy Advisor - 13 hours ago]
First reported 14 hours ago - Updated 14 hours ago - 1 reports

CD44 variant 6 is associated with prostate cancer metastasis and chemo-/radioresistance - Abstract

INTRODUCTION: Prostate cancer (CaP) is the second leading malignancy in older men in Western countries.The role of CD44 variant 6 (CD44v6) in CaP progression and therapeutic resistance is still uncertain. Here, we investigated the roles of CD44v6 in CaP ... [Published UroToday - 14 hours ago]
First reported Apr 18 2014 - Updated Apr 18 2014 - 1 reports

Research Data from King Saud University Update Understanding of Cervical Cancer

(NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- New research on Oncology is the subject of a report. According to news originating from Riyadh, Saudi Arabia, by NewsRx correspondents, research stated, "The aim of the study ... [Published NewsRX - Apr 18 2014]
First reported Apr 17 2014 - Updated Apr 17 2014 - 1 reports

Palliative Radiotherapy for Prostate Cancer

ABSTRACT: Radiotherapy is an effective tool for the palliation of symptoms commonly caused by prostate cancer. The majority of painful bone metastases respond equally well to single or multiple fractions of external radiotherapy. Retreatment with a second ... [Published Consultant Live - Apr 17 2014]
First reported Apr 17 2014 - Updated Apr 17 2014 - 1 reports

Kidney cancer

refers to most types of renal cancer that occur in the kidneys (accounting for more than 85 percent). Kidney cancer accounts for approximately 1.6 percent of all cancers that occur in Korea, according to data from 2002. It is twice as likely to occur ... [Published Korea Herald - Apr 17 2014]
First reported Apr 17 2014 - Updated Apr 17 2014 - 1 reports

Researchers from Siemens Detail New Studies and Findings in the Area of Gastroenterology

By a News Reporter-Staff News Editor at Gastroenterology Week -- Investigators publish new report on Gastroenterology. According to news reporting out of Forchheim, Germany , by NewsRx editors, research stated, "To compare in dual-energy CT (DECT) conventionally ... [Published 4 Traders - Apr 17 2014]
First reported Apr 17 2014 - Updated Apr 17 2014 - 1 reports

MEDICAL SCIENCES : Investigators from Poznan University of Medical Sciences Target Thyroid Cancer

By a News Reporter-Staff News Editor at Cancer Weekly -- A new study on Oncology is now available. According to news originating from Poznan, Poland , by NewsRx correspondents, research stated, "The purpose of the study was to assess the feasibility of ... [Published 4 Traders - Apr 17 2014]
First reported Apr 16 2014 - Updated Apr 16 2014 - 1 reports

NCCN Survivorship Guidelines Now Include Chemobrain

Image ToolsHOLLYWOOD, Fla.—A major hurdle in developing guidelines for the treatment of cancer-associated cognitive dysfunction—now usually called chemobrain—was first getting the medical field to believe that it actually existed. So said Elizabeth Kvale, ... [Published Oncology Times - Apr 16 2014]
First reported Apr 16 2014 - Updated Apr 16 2014 - 2 reports

NICE recommends FIRMAGON for treating advanced hormonedependent prostate cancer in adults with spinal metastases

The National Institute for Health and Care Excellence (NICE) today issued its Final Appraisal Determination (FAD) recommending FIRMAGON (degarelix) as an option for treating advanced hormone-dependent prostate cancer, only in adults with spinal metas ... [Published BioPortfolio - Apr 16 2014]
First reported Apr 15 2014 - Updated Apr 15 2014 - 6 reports

NICE Recommends Firmagon for Special Cases of Advanced Prostate Cancer

The National Institute for Health and Care Excellence (NICE) issued its Final Appraisal Determination (FAD) recommending Firmagon (degarelix) as an option for treating advanced hormone -dependent prostate cancer , only in adults with spinal metastases ... [Published BioPortfolio - Apr 15 2014]
First reported Apr 15 2014 - Updated Apr 15 2014 - 3 reports

UK NICE guidance recommends FIRMAGON® (degarelix) for the treatment of advanced hormone-dependent prostate cancer only in people with spinal metastases who present with signs or symptoms of impending spinal cord compression (ISCC)

WEST DRAYTON, England--(BUSINESS WIRE)--The National Institute for Health and Care Excellence (NICE) today issued its Final Appraisal Determination (FAD) recommending FIRMAGON® (degarelix) as an option for treating advanced hormone-dependent prostate ... [Published Business Wire Science: Science News - Apr 15 2014]
First reported Apr 12 2014 - Updated Apr 12 2014 - 1 reports

Brain metastases in melanoma require multidisciplinary approach

NEW YORK — Brain metastases are responsible for the majority of mortality and morbidity among patients with melanoma, and a multidisciplinary approach is necessary to effectively manage this complication, according to a presenter at the HemOnc Today Melanoma ... [Published Orthopedics Today - Apr 12 2014]

Quotes

...Robert J Lewandowski, MD, associate professorprofessor of radiology at Northwestern University Feinberg School of Medicine in Chicago, Illinois. "The treatment is not limited by tumor size, shape, location, or number.”"
...responses in advanced prostate cancer patients," said Andrew S Sandler, M D , executive vice president and chief medical officer at Dendreon. "The presentation of these data at EAU highlights Dendreon's commitment to expanding awareness and understanding of immunotherapy and PROVENGE in Europe as we prepare to make PROVENGE available to advanced prostate cancer patients beyond the US."
...According to news originating from Riyadh, Saudi Arabia, by NewsRx correspondents, research stated, "The aim of the study was to assess oncologic and fertility outcome of treatment in patients with cervical cancer of more than 2 cm seeking parenthood. The regimen consisted of laparoscopic lymphadenectomy as a staging procedure to confirm no lymph node metastases before neoadjuvant chemotherapy (NACT) consisting of 2 or 3 cycles of paclitaxel/ifosfamide/cisplatin followed by radical vaginal trachelectomy (RVT)."
...According to news originating from Hershey, Pennsylvania, by NewsRx correspondents, research stated, "Skeletal metastases of breast cancer and subsequent osteolysis connote a dramatic change in the prognosis for the patient and significantly increase the morbidity associated with disease. The cytokine interleukin 8 (IL-8/CXCL8) is able to directly stimulate osteoclastogenesis and bone resorption in mouse models of breast cancer bone metastasis."

More Content

All (501) | News (458) | Reports (0) | Blogs (37) | Audio/Video (0) | Fact Sheets (2) | Press Releases (1)
sort by: Date | Relevance
Y-90 radioembolization: A new treatment for hep... [Published Chemotherapy Advisor - 13 hours ago]
CD44 variant 6 is associated with prostate canc... [Published UroToday - 14 hours ago]
Testicular manifestation of a transformed mycos... [Published UroToday - 16 hours ago]
Dendreon announces encouraging data from Phase ... [Published Individual.com - Apr 18 2014]
Research Data from King Saud University Update ... [Published NewsRX - Apr 18 2014]
Researchers at Pennsylvania State University Ha... [Published NewsRX - Apr 18 2014]
Lumiphore advances its site-directed radiopharm... [Published Digital Journal - Apr 17 2014]
Ansell Capital Corp. : Announces Proposed Rever... [Published 4 Traders - Apr 17 2014]
Ansell Capital Corp. Announces Proposed Reverse... [Published BusinessWeek - Apr 17 2014]
Ferring's Firmagon receives recommendation from... [Published Zenopa - Apr 17 2014]
NICE limits approval for Ferring's prostate can... [Published Pharmaceutical Technology - Apr 17 2014]
Kidney cancer [Published Korea Herald - Apr 17 2014]
Very High-Risk Localized Prostate Cancer [Published General Medicine eJournal - Apr 17 2014]
Dendreon Releases Preliminary Data from Analysi... [Published Individual.com - Apr 17 2014]
Researchers from Siemens Detail New Studies and... [Published 4 Traders - Apr 17 2014]
MEDICAL SCIENCES : Investigators from Poznan Un... [Published 4 Traders - Apr 17 2014]
Reports from Z.B. Song et al Highlight Recent F... [Published HispanicBusiness.com - Apr 17 2014]
Large Renal Mass: A Challenge for the Urologist [Published Cancernetwork.com - Apr 17 2014]
Dabrafenib: Also no added benefit over vemurafenib [Published HispanicBusiness.com - Apr 17 2014]
ONCOLYTICS BIOTECH INC. : Collaborators Present... [Published 4 Traders - Apr 17 2014]
Palliative Radiotherapy for Prostate Cancer: En... [Published Consultant Live - Apr 17 2014]
Palliative Radiotherapy for Prostate Cancer [Published Consultant Live - Apr 17 2014]
Ride Cincinnati Grants Help Fund Influential Re... [Published University of Cincinnati - Apr 16 2014]
Total Parotidectomy Best Option for Metastatic ... [Published Diabetes Care - Apr 16 2014]
MicroRNA's role in breast cancer metastasis ide... [Published Science Daily - Apr 16 2014]
GI Research Improving Quality of Life in Rectal... [Published Oncology Times - Apr 16 2014]
NCCN Survivorship Guidelines Now Include Chemob... [Published Oncology Times - Apr 16 2014]
NICE gives partial backing to Ferring's prostat... [Published PMLive - Apr 16 2014]
DelMar announces encouraging results from Phase... [Published Individual.com - Apr 16 2014]
Image Guided Tumour Ablation - Latest Cancer Th... [Published Total Health - Apr 16 2014]
1 2 3 4 5 6 7 8 9 10 ...
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
UK NICE guidance recommends FIRMAGON® (degareli... [Published Business Wire Science: Science News - Apr 15 2014]
WEST DRAYTON, England--(BUSINESS WIRE)--The National Institute for Health and Care Excellence (NICE) today issued its Final Appraisal Determination (FAD) recommending FIRMAGON® (degarelix) as an option for treating advanced hormone-dependent prostate ...
UK NICE guidance recommends FIRMAGON® (degareli... [Published EON Science - Apr 15 2014]
WEST DRAYTON, England--(EON: Enhanced Online News)--The National Institute for Health and Care Excellence (NICE) today issued its Final Appraisal Determination (FAD) recommending FIRMAGON® (degarelix) as an option for treating advanced hormone-dependent ...
UK NICE guidance recommends FIRMAGON® (degareli... [Published Business Wire Health News - Apr 15 2014]
WEST DRAYTON, England--(BUSINESS WIRE)--The National Institute for Health and Care Excellence (NICE) today issued its Final Appraisal Determination (FAD) recommending FIRMAGON® (degarelix) as an option for treating advanced hormone-dependent prostate ...
NICE draft guidance recommends a treatment for ... [Published NICE | National Institute for Health and Clinic ... - Apr 15 2014]
In final draft guidance published today (15 April, 2014), NICE has recommended degarelix (Firmagon, Ferring Pharmaceuticals), as an option for treating advanced hormone dependent prostate cancer in people with spinal metastases who present with signs ...
Dendreon to present long-term Phase II STAND st... [Published PBR - News - Apr 14 2014]
Dendreon has announced the presentation of preliminary data from a long-term analysis of the Phase II STAND study demonstrating that tumor-specific T-cell responses appear to be enhanced and sustained when Provenge (sipuleucel-T) is given after androgen ...
1 2 3 4 5 6 7 8

Press Releases

sort by: Date | Relevance
Myriad's Prolaris(R) Test Significantly Modifie... [Published GlobeNewswire: Acquisitions News - Jan 29 2014]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.